全球 Schaaf-Yang 综合征治疗市场，按治疗（物理治疗、职业治疗、言语治疗）、最终用户（医院、研究机构、专科诊所）、分销渠道（医院药房、零售药房、网上药房和其他）划分 - 行业趋势和预测至 2029 年
夏夫-杨综合征治疗市场分析和规模
预测期内，Schaaf-Yang 综合征治疗市场预计将出现显著增长。为受这种严重疾病综合征影响的患者提供的设施的增加直接影响了 Schaaf-Yang 综合征治疗市场的增长。Schaaf-Yang 综合征的全球患病率不到 1/1,000,000。对这些疾病进行准确和适当诊断的需求日益增加，预计将对市场产生重大影响。COVID-19 也对市场增长产生了重大影响。
Data Bridge Market Research 分析了 2022-2029 年预测期内 Schaaf-Yang 综合征治疗市场的增长率。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
市场定义
夏夫-杨综合征是一种罕见的遗传性疾病，其特征是肌张力低下、智力障碍、发育迟缓和自闭症谱系障碍。该综合征是由 15 号染色体上的MAGEL2 基因的遗传变异引起的。该综合征的大多数病例都是新生突变引起的。这种疾病的发病率正在上升，因此对医疗保健行业非常重要。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按治疗（物理治疗、职业治疗、语言治疗）、最终用户（医院、研究机构、专科诊所）、分销渠道（医院药房、零售药房、网上药房和其他） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Teleflex, Incorporated. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co Ltd (China), Virchow Biotech (India), Alexion Pharmaceuticals, Inc. (U.S.), Sanofi (France), Takeda Pharmaceutical Company Limited (Japan), Vertex Pharmaceuticals Incorporated (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Amgen Inc. (U.S.), Jazz Pharmaceuticals, Inc. (U.S.), Pfizer Inc (U.S.), PerkinElmer Inc (U.S.), Bio-Rad Laboratories, Inc. (U.S.), BioMarin (U.S.), Sarepta Therapeutics Inc. (U.S.), ICU Medical Inc (U.S.), Moog Inc. (U.S.), AVNS. (U.S.), Nipro (Japan), ATRICURE INC (U.S.) |
|
Market Opportunities |
|
Global Schaaf-Yang Syndrome Treatment Market Dynamics
Drivers
- Increase in Advanced Treatments
Different treatment procedures used in this disease are boosting the market growth. Treatments such as physical therapy, speech therapy and high-end genetic counseling in some cases increases the patients' recovery chances. Thus, it acts as a major driver in the market growth.
- Increasing Awareness of Healthcare Infrastructure
Another significant factor influencing the growth rate of schaaf-yang syndrome treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aim to improve the healthcare infrastructure by increasing funding, which will further influence the market dynamics.
Opportunities
- Increase in Obesity
Around 13% of adults in the world are witnessed as obese. Approximately 39% of adults in the world are considered to be overweight. Globally, one-in-five children and adolescents are overweight. It leaves a great impact on the growth of this market.
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the global schaaf-yang syndrome treatment market. To encourage researchers and pharmaceutical companies to develop novel medicines, the government is funding research and development (R&D) initiatives.
Restraints/Challenges
- Lack of Awareness
The sales of potential products are not succeeding much due to the less awareness of the syndrome. Though effective treatments are available, but beliefs, poor inadequate communication between clinicians and patients, treatment adherence are the factors hindering the market growth.
- High Cost
The huge expenditure required for the treatment processes surely hamper the market growth. Several market players make huge investment in installing new and advanced treatment procedures to faster the recovery process and in return the cost is increased.
这份沙夫-杨氏综合征治疗市场报告提供了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用利基和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关沙夫-杨氏综合征治疗市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
COVID-19 对全球 Schaaf-Yang 综合征治疗市场的影响
从目前的情况来看，COVID-19 已造成前所未有的全球公共卫生危机，几乎影响到所有企业。其长期影响预计将在预测期内影响行业增长。
随着患者人数的快速增加，医疗机构和专业人员的负担也随之增加。许多医院决定取消或推迟手术。疫情对沙夫-杨综合征治疗市场的影响喜忧参半。疫情给整体治疗程序带来了压力。由于封锁和旅行限制，医院数量减少，世界各地取消了无数次手术。
全球 Schaaf-Yang 综合征治疗市场范围
沙夫-杨综合征治疗市场根据治疗、分销渠道和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
治疗
- 物理治疗
- 职业治疗
- 言语治疗
终端用户
- 医院
- 研究机构
- 专科诊所
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他的
沙夫-杨综合征治疗市场区域分析/见解
对夏夫-杨综合征治疗市场进行了分析，并按治疗、分销渠道和最终用户提供了市场规模洞察和趋势。
夏夫-杨氏综合征治疗市场报告涉及的主要国家 有：北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区
由于该疾病的流行，北美在预测期内占据市场主导地位。
由于亚太地区患者数量不断增加且可支配收入水平不断飙升，该地区被认为正处于最有利可图的时期。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球 Schaaf-Yang 综合征治疗市场份额分析
沙夫-杨综合征治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对沙夫-杨综合征治疗市场的关注有关
夏夫-杨综合征治疗市场的主要参与者包括：
- Teleflex, Incorporated。（美国）
- 深圳迈瑞生物医疗电子股份有限公司 (中国)
- Virchow Biotech（印度）
- Alexion Pharmaceuticals, Inc.（美国）
- 赛诺菲（法国）
- 武田药品工业株式会社 (日本)
- Vertex Pharmaceuticals Incorporated（美国）
- F. Hoffmann-La Roche Ltd（瑞士）
- 雅培（美国）
- 安进公司 (美国)
- Jazz Pharmaceuticals, Inc.（美国）
- 辉瑞公司 (美国)
- PerkinElmer Inc（美国）
- Bio-Rad Laboratories, Inc.（美国）
- BioMarin (美国)
- Sarepta Therapeutics Inc.（美国）
- ICU Medical Inc（美国）
- Moog Inc.（美国）
- AVNS。（美国）
- 尼普洛（日本）
- ATRICURE INC（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
